THE NEW CLINICAL PROGRAM DEVELOPMENT CORPORATION (EIN 061565494) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

GAIL KOSYLA

Phone

2036882603

Tax Period

2024-10-01 to 2025-03-03

THE NEW CLINICAL PROGRAM DEVELOPMENT CORPORATION, founded in 1999, is a micro nonprofit that reported $108 in total revenue in fiscal year 2024. Revenue fell 60% from the prior year — a significant decline worth monitoring.

Mission

TO PROVIDE SUPPORT FOR THE DEVELOPMENT OF NEW AND INNOVATIVE CLINICAL PROGRAMS AND SERVICES THAT WILL ENHANCE THE RENDERING OF PATIENT CARE AT THE YALE UNIVERSITY SCHOOL OF MEDICINE AND YALE NEW HAVEN HOSPITAL.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $108

Other Revenue $0

TOTAL REVENUE $108

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $0

TOTAL EXPENSES $0

Year-over-Year Comparison

	2024	2023	Change
Revenue	$108	$270	-0.6%
Expenses	N/A	N/A	N/A
Net Income	N/A	$270	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARGARET MCGOVERN	PRESIDENT & DIRECTOR	1.00	Officer Director	$0	$0	$0
ARNIM DONTES	TREASURER & DIRECTOR	1.00	Officer Director	$0	$0	$0
GAIL KOSYLA	SECRETARY & DIRECTOR	1.00	Officer Director	$0	$0	$0
KATHERINE HEILPERN	CHAIRMAN & DIRECTOR	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$108	No data	No data	No data
2024	$270	No data	$5,564	No data
2023	$218	No data	$5,294	No data
2022	$40,000,002	$40,000,000	$5,063	$2
2022	$40,000,013	$40,000,000	$5,076	$13
2021	$40,000,002	$40,000,000	$5,061	$2
2020	$40,000,059	$40,000,000	$5,059	$59
2019	$40,000,000	$40,000,000	$5,000	No data
2018	$40,000,000	$40,000,000	$5,000	No data

THE NEW CLINICAL PROGRAM DEVELOPMENT CORPORATION